Moderna seeking Hong Kong regulatory approval for Omicron-targeted Covid-19 booster vaccine

Patrick Bergstedt, US company’s senior vice-president of commercial vaccines, says discussions with city government at advanced stage, but no green light given yet.

Read the original article at South China Morning Post